Investing.com - Financial Markets Worldwide

Sinovac Biotech Ltd (SVA)

NASDAQ
Currency in USD
6.470
0.000(0.00%)
Real-time Data·
Showing Sinovac Biotech historical data. For real-time data please try another search
Day's Range
6.2506.580
52 wk Range
0.0006.580
Key Statistics
Edit
Prev. Close
6.47
Open
6.49
Day's Range
6.25-6.58
52 wk Range
0-0
Volume
-
Average Volume (3m)
167.66K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Sinovac Biotech Ltd News & Analysis

Show more

Sinovac Biotech Ltd Company Profile

Sinovac Biotech Ltd., through its subsidiaries, operates as a biopharmaceutical company that focuses on the research, development, manufacture, and commercialization of vaccines against human infectious diseases in China. The company's product portfolio includes vaccines against hepatitis A and B; hand, foot, and mouth diseases caused by enterovirus 71 (EV71); seasonal influenza; H5N1 and H1N1 pandemic influenza; coronavirus; varicella; and mumps. Its marketed products, include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine to treat viral disease in human species; split viron pandemic influenza vaccine; and Inlive, an EV71 vaccine. The company also offers varicella; pneumococcal polysaccharide vaccine; quadrivalent influenza vaccine; and CoronaVac, a vaccine against COVID-19. In addition, its pipeline products include sabin inactivated polio vaccine; and rubella vaccine. Sinovac Biotech Ltd. was formerly known as Net-Force System Inc. and changed its name to Sinovac Biotech Ltd. in October 2003. The company was incorporated in 1999 and is based in Beijing, China.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
3037
Market
United States

Earnings

Latest Release
Aug 16, 2024
EPS / Forecast
-0.11 / --
Revenue / Forecast
121.34M / --
EPS Revisions
a
a
Unlock
Last 90 days

SVA Income Statement

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.